BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3907198)

  • 1. [Results of radiotherapeutic optimization within the scope of combined operative-radiologic therapy of urinary bladder cancer].
    Kob D; Kloetzer KH; Kriester A; Arndt J; Bockhorn V; Möller A; Bothor C; Pirlich W
    Z Urol Nephrol; 1985 Oct; 78(10):545-50. PubMed ID: 3907198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of percutaneous radiotherapy of bladder cancer using 1 and 2 series of irradiation].
    Kob D; Arndt J; Kriester A; Schwenk M; Kloetzer KH
    Strahlentherapie; 1985 Nov; 161(11):673-7. PubMed ID: 3907021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study].
    Zapatero A; Pinar B; Arellano R; López M; Marín A; Jiménez U; Pérez Torrubia A
    Arch Esp Urol; 1997 Jun; 50(5):448-54; discussion 454-6. PubMed ID: 9382586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of recurrence using telecobalt and betatron irradiation after transurethral resection of bladder tumors].
    Flamm J
    Wien Med Wochenschr; 1983; 133(7):175-7. PubMed ID: 6868628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of long-term treatment of inoperable cancer of the bladder with cisplatin and concurrent irradiation: prognostic factors of local control and survival].
    Chauvet B; Félix-Faure C; Davin JL; Choquenet C; Alfonsi M; Reboul F
    Cancer Radiother; 1998 Apr; 2 Suppl 1():85s-91s. PubMed ID: 9749086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cobalt therapy prophylaxis of recurrence of T1 bladder cancer.
    Pow-Sang J; Zaharia M; Ramirez G; Garcia J; Benavente V; Gonzales J
    Prog Clin Biol Res; 1984; 162B():33-7. PubMed ID: 6504903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings: Megavoltage irradiation for bladder cancer: alone, postoperative, or preoperative?
    Miller LS; Johnson DE
    Proc Natl Cancer Conf; 1972; 7():771-82. PubMed ID: 4203019
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of the combined treatment of bladder cancer patients].
    Aslamazov EG; Doldurov GS; Sarkisian IuKh; Agafonova GB
    Urol Nefrol (Mosk); 1984; (4):27-30. PubMed ID: 6474624
    [No Abstract]   [Full Text] [Related]  

  • 10. Transurethral resection for muscle-invasive bladder cancer.
    Kondás J; Váczi L; Szecsó L; Kondér G
    Int Urol Nephrol; 1993; 25(6):557-63. PubMed ID: 8175277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organ-sparing treatment in muscle-invasive bladder cancer.
    Dunst J; Diestelhorst A; Kühn R; Müller AC; Scholz HJ; Fornara P
    Strahlenther Onkol; 2005 Oct; 181(10):632-7. PubMed ID: 16220401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cancer of the bladder. Results of radiotherapy after partial cystectomy].
    Di Pietrantonj F; Capirci C; Proietti A; Cardinali M
    Radiol Med; 1985; 71(7-8):510-6. PubMed ID: 4081133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of bladder-conserving treatment, consisting of brachytherapy combined with limited surgery and external beam radiotherapy, for patients with solitary T1-T3 bladder tumors less than 5 cm in diameter.
    Blank LE; Koedooder K; van Os R; van de Kar M; van der Veen JH; Koning CC
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):454-8. PubMed ID: 17560734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two-port and four-port irradiation in the bladder preservation therapy for locally invasive bladder cancer.
    Sawada Y; Takeuchi Y; Iwasawa T; Kuroda K; Matsushima M; Nagamoto M; Wakayama M
    Int J Urol; 2006 Dec; 13(12):1470-4. PubMed ID: 17118019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cobalt teletherapy of the carcinoma of the urinary bladder (author's transl)].
    Jend HH; Konstantinidis E; Rühl U
    Strahlentherapie; 1979 Nov; 155(11):740-7. PubMed ID: 516093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of telecobalt therapy in non-radically operated bladder neoplasms].
    Kamprad F; Pfeiffer J; Oelssner W
    Z Urol Nephrol; 1978 Feb; 71(2):107-13. PubMed ID: 645243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radiogenic alterations following telecobalt irradiation of urinary bladder tumors].
    Kamprad F; Pfeiffer J
    Z Urol Nephrol; 1978 Aug; 71(8):541-6. PubMed ID: 726690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bladder-sparing therapy for muscle-infiltrating bladder cancer.
    Pansadoro V; Emiliozzi P
    Nat Clin Pract Urol; 2008 Jul; 5(7):368-75. PubMed ID: 18560383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radical pelvic surgery versus radical surgery plus radiotherapy for stage Ib carcinoma of the cervix uteri. Preliminary results of a prospective randomized clinical study.
    Bilek K; Ebeling K; Leitsmann H; Seidel G
    Arch Geschwulstforsch; 1982 May; 52(3):223-9. PubMed ID: 6751268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life in patients with advanced bladder cancer. A randomized study comparing cystectomy and irradiation--the Danish Bladder Cancer Study Group (DAVECA protocol 8201).
    Mommsen S; Jakobsen A; Sell A
    Scand J Urol Nephrol Suppl; 1989; 125():115-20. PubMed ID: 2699072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.